ロード中...
Medical Treatment of Benign Prostatic Hyperplasia
Medical therapy for the treatment of benign prostatic hyperplasia (BPH) became an accepted standard of care in the 1990s following the reports of randomized, double-blind, placebo-controlled studies showing that finasteride, a 5-α reductase inhibitor, and terazosin, an α-blocker, significantly impro...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MedReviews, LLC
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3151584/ https://ncbi.nlm.nih.gov/pubmed/21826125 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|